58 results
424B3
COYA
Coya Therapeutics Inc
24 Jun 24
Prospectus supplement
5:31pm
by us in connection with this registration. We will not be responsible for fees and expenses incurred by the selling stockholder or any underwriting
8-K
EX-10.1
COYA
Coya Therapeutics Inc
20 May 24
Coya Therapeutics Announces $5 Million Strategic
5:00pm
, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company … , the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated
424B3
85v3 j8h9v9gk2dea3t
16 Jan 24
Prospectus supplement
4:06pm
UPLOAD
xs733dy15nnlh
9 Jan 24
Letter from SEC
12:00am
S-3
0k20dq
4 Jan 24
Shelf registration
4:46pm
8-K
EX-4.1
yy53wix
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.1
ujlsbgq4y1u 4zbkvjj
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-99.1
g31a9rb7m20qqoi
6 Dec 23
Entry into a Material Definitive Agreement
7:30am